Abstract
In their piece, Herder and colleagues (2022) reveal the university origins of a key technology used in COVID-19 mRNA vaccines. They note that despite federal funding support and the university adopting"Global Access Principles," equitable, global access remains a challenge – in part due to the university's technology transfer practices. While for the past two decades university students have been successful in engaging institutional technology transfer offices in adopting similar access principles, implementation of these principles has been limited. This rejoinder points to the need for greater federal oversight and regulation to incentivize university action that enables equitable, global access.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
